NCT03247361

Brief Summary

It is well-known that muscle weakness and deconditioning play an important role in low exercise capacity of patients with HF. Interestingly, not only peripheral muscles are impaired, but also respiratory muscles. Studies have shown that patients with HF may have, in addition to decreasing maximal inspiratory muscle strength and endurance, metabolic and structural impairments in diaphragm fibers. Moreover, exercise capacity and weakness of inspiratory muscles have been associated with low quality of life and poor prognosis, which make the addition of inspiratory muscle training (IMT) reasonable in cardiovascular rehabilitation.The specifications of the loads to be imposed during IMT is the main factor determining the outcome. Studies of IMT have highlighted the need for a fixed inspiratory workload during exercise. Thus, purpose of this report was to perform a randomized clinical trial of the effects of addition of high-intensity vs. low-intensity IMT to combined aerobic and resistance Exercise in patients with heart failure.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable heart-failure

Timeline
Completed

Started Aug 2017

Typical duration for not_applicable heart-failure

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2017

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

August 9, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 11, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2020

Completed
Last Updated

November 7, 2018

Status Verified

November 1, 2018

Enrollment Period

2 years

First QC Date

August 9, 2017

Last Update Submit

November 5, 2018

Conditions

Keywords

Heart Failure; Rehabilitation

Outcome Measures

Primary Outcomes (2)

  • Aerobic Capacity

    Six-minute walk test

    10 weeks

  • Health-Related Quality of Life: MLHFQ

    Health-Related Quality of Life will be measured by a questionnaire (Minnesota Living with Heart Failure questionnaire - MLHFQ)

    10 weeks

Secondary Outcomes (2)

  • Respiratory muscle strength

    10 weeks

  • Disability

    10 weeks

Study Arms (3)

High-intensity IMT

EXPERIMENTAL

High-intensity IMT + Aerobic/resistance exercise IMT: Training loads will be adjusted weekly to the maximal inspiratory pressure (MIP). In the first 2 weeks as adaptation, the protocol will be of 2 minutes warm-up with intensity 20% of MIP. The training will have 7 peaks of intensity with 70% of MIP for 30 sec, with 30-sec of passive rest between the peaks, finishing the training with 20% of MIP for 2 min, totaling 10 min and 30 sec. From the third week the protocol will be of 2 min warm-up with intensity 30% of MIP. The training will have 7 peaks of intensity with 70% of MIP for 60 sec, with 60-second of passive rest between the peaks, finishing the training with 20% of MIP for 2 min, totaling 17 min. Exercise: see group Combined aerobic/resistance exercise

Other: High-intensity IMT + Aerobic/resistance exercise

Low-intensity IMT

ACTIVE COMPARATOR

Low-intensity IMT + Aerobic/resistance exercise IMT:Training loads will be also adjusted weekly to the maximal inspiratory pressure (MIP). In the first two weeks as adaptation, the protocol will be of 2 minutes warm-up with intensity 20% of MIP. The training will be held with 3 sets of 15 repetitions, with 40% of MIP, finishing the training with 20% of MIP for 2 minutes. From the third week the protocol will be of 2 minutes warm-up with intensity 30% of MIP. The training will be held with 3 sets of 15 repetitions, with 60% of MIP, finishing the training with 30% of MIP for 2 minutes. Exercise: see group Combined aerobic/resistance exercise

Other: Low-intensity IMT + Aerobic/resistance exercise

Aerobic/resistance exercise

SHAM COMPARATOR

Sham IMT + Aerobic/resistance exercise Aerobic session will consist of a 4-min of warm-up, 20 minutes of exercise, and 4 min of cool-down. Intensity will set by the formula: Training HR = (maximum HR - resting HR) × intensity % + resting HR. Patients will exercise using 30 seconds, high-intensity work phases 0.7% followed by 1-minute recovery bouts 0.5%. Resistance exercise will consist of dynamic lower and upper limb exercise. Upper limb exercises will include 3 sets of exercises for each muscle group performed with 10 repetitions each. Lower limb exercises will include 3 sets of exercises for each muscle group performed with 12 repetitions each. Resistance exercises will be performed at 12-MR.

Other: Sham IMT + Aerobic/resistance exercise

Interventions

High-intensity IMT

High-intensity IMT

Low-intensity IMT

Low-intensity IMT

Aerobic and resistance exercise

Aerobic/resistance exercise

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The target population consists of adults patients aged ≥ 18 years with heart failure and New York Heart Association (NYHA) class I-III.

You may not qualify if:

  • Unstable angina;
  • coronary revascularization;
  • Decompensated heart failure functional class IV (NYHA);
  • Recent transplant or hospitalization (6 months \<);
  • Chronic Obstructive Pulmonary Disease;
  • Neuromuscular, Orthopedic, Neurologic and Neoplastic Diseases;
  • Recent myocardial infarction or cardiac surgery (less than 6 months);
  • Atrial Fibrillation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansueto Gomes Neto

Salvador, Estado de Bahia, 40100-110, Brazil

RECRUITING

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Mansueto Gomes-Neto, PhD

    Federal University of Bahia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mansueto Gomes-Neto, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal researcher

Study Record Dates

First Submitted

August 9, 2017

First Posted

August 11, 2017

Study Start

August 1, 2017

Primary Completion

August 1, 2019

Study Completion

August 1, 2020

Last Updated

November 7, 2018

Record last verified: 2018-11

Locations